Stay up to date with notifications from The Independent

Notifications can be managed in browser preferences.

France clinical trial: One person brain-dead and five in hospital after drug testing 'accident' in Rennes

The health ministry has not yet confirmed what the drug undergoing testing was

Lizzie Dearden
Friday 15 January 2016 06:40 EST
Comments
Biotrial laboratory building in Rennes where a clinical trial took place
Biotrial laboratory building in Rennes where a clinical trial took place (Getty Images)

Your support helps us to tell the story

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.

At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.

The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.

Your support makes all the difference.

One person has been left “brain-dead” and five more have been hospitalised after a clinical trial on an experimental drug went wrong in France.

The health ministry said the “serious accident” happened on Thursday, stopping the tests and forcing all volunteers to be recalled.

A statement released today did not confirm the name of the drug being tested but French media reports claimed it was a new cannabinoid-based painkiller.

Marisol Touraine, the French health minister, later said that the pill did not contain cannabis or its derivatives but acted on the body's endocannabinoid system.

Taken orally, the drug was undergoing a Phase 1 clinical trial at a licensed private European laboratory that specialises in clinical trials, the French health ministry said.

The trial aimed to evaluate the “safety, tolerance and pharmaceutical properties of the molecule” in healthy volunteers.

“Marisol Touraine wants to express her solidarity and deep determination to get to the bottom of what happened and establish responsibility for this tragic accident,” a statement added.

One of the six volunteers is currently in intensive care at Rennes University Hospital, where the other five are also being treated.

France’s medicines agency (ANSM) has launched an investigation into the laboratory.

Join our commenting forum

Join thought-provoking conversations, follow other Independent readers and see their replies

Comments

Thank you for registering

Please refresh the page or navigate to another page on the site to be automatically logged inPlease refresh your browser to be logged in